Pyrimidine Synthesis Inhibitor

All categories
Name
Pyrimidine Synthesis Inhibitor
Accession Number
DBCAT003496
Description

Not Available

Drugs
DrugDrug Description
TeriflunomideA pyrimidine synthesis inhibitor with anti-inflammatory and immunomodulatory properties used to treat patients with the relapsing-remitting form of multiple sclerosis.
Drugs & Drug Targets
DrugTargetType
TeriflunomideATP-binding cassette sub-family G member 2transporter
TeriflunomideDihydroorotate dehydrogenase (quinone), mitochondrialtarget
TeriflunomideCytochrome P450 2C8enzyme
TeriflunomideSolute carrier organic anion transporter family member 1B1transporter
TeriflunomideCytochrome P450 1A2enzyme